Breast Cancer: Recurrent Genomic Alterations: Difference between revisions
| [unchecked revision] | [unchecked revision] |
adding reference |
mNo edit summary |
||
| Line 75: | Line 75: | ||
Abbreviations: TNBC, triple negative breast cancer; LOH, loss of heterozygosity. | Abbreviations: TNBC, triple negative breast cancer; LOH, loss of heterozygosity. | ||
'''Table 2 - Major clinically significant genes associated with somatic sequence alterations in breast cancer.''' Table derived from Geiersbach et al., 2018 [[https://pubmed.ncbi.nlm.nih.gov/32087595/ < | |||
'''Table 2 - Major clinically significant genes associated with somatic sequence alterations in breast cancer.''' Table derived from Geiersbach et al., 2018 [<nowiki>[https://pubmed.ncbi.nlm.nih.gov/32087595/ |#mwt5|mw:ExpandedAttrs|{"attribs":[[{"txt":"href"},{"html":"https://pubmed.ncbi.nlm.nih.gov/32087595/ <span typeof=\"mw:Nowiki\" data-parsoid='{\"dsr\":[2320,2350,8,9]}'>PMID 32087595</span>"}]</nowiki>]}]] with permission from Cancer Genetics. | |||
{| class="wikitable" | {| class="wikitable" | ||
|'''Gene(s)''' | |'''Gene(s)''' | ||
| Line 259: | Line 260: | ||
'''Table 3 - Genes with known hereditary risk associations in breast cancer.''' Table derived from Geiersbach et al., 2018 [[https://pubmed.ncbi.nlm.nih.gov/32087595/ < | '''Table 3 - Genes with known hereditary risk associations in breast cancer.''' Table derived from Geiersbach et al., 2018 [<nowiki>[https://pubmed.ncbi.nlm.nih.gov/32087595/ |#mwt11|mw:ExpandedAttrs|{"attribs":[[{"txt":"href"},{"html":"https://pubmed.ncbi.nlm.nih.gov/32087595/ <span typeof=\"mw:Nowiki\" data-parsoid='{\"dsr\":[5592,5622,8,9]}'>PMID 32087595</span>"}]</nowiki>]}]] with permission from Cancer Genetics. | ||
{| class="wikitable" | {| class="wikitable" | ||
|'''Gene''' | |'''Gene''' | ||